nimodipine

Nimodipine (BAY-e 9736), a 1, 4-dihydropyridine calcium channel blocker, acts primarily on vascular smooth muscle cells.

(R)-Nimodipine ((R)-BAY-e 9736) is an enantiomer of Nimodipine. Nimodipine (BAY-e 9736) is an orally active, well-tolerated, photosensitive dihydropyridine calcium antagonist. It can be used in the study of cerebrovascular diseases.

(S)-Nimodipine ((S)-BAY-e 9736) is an enantiomer of Nimodipine (BAY-e 9736), which is an orally active, well-tolerated, photosensitive dihydropyridine calcium antagonist. Nimodipine is utilized in the research of cerebrovascular diseases.

Nimodipine-D7 is a deuterated compound of Nimodipine. Nimodipine (T0343) has a CAS number of 66085-59-4. Nimodipine, a 1, 4-dihydropyridine calcium channel blocker, acts primarily on vascular smooth muscle cells.

Nimodipine (Standard) is the standard substance of Nimodipine, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Nimodipine (BAY-e 9736), a 1, 4-dihydropyridine calcium channel blocker, acts primarily on vascular smooth muscle cells.

Nimodipine-D7 (Standard) is a reference standard of Nimodipine-D7 intended for quantitative analysis, quality control, and related biochemical research applications. Nimodipine-d7 is a deuterated compound of Nimodipine. Nimodipine has a CAS number of 66085-59-4. Nimodipine, a 1, 4-dihydropyridine calcium channel blocker, acts primarily on vascular smooth muscle cells.

1. Dihydrolycorine-HCL(DL) shows hypotensive effects, it can block alpha 1-adrenoceptors. 2. Dihydrolycorine is an inhibitors of protein synthesis in eukarytic cells, it halts protein synthesis in eukaryotic cells by inhibiting the peptide bone formation